Understand the clinical journey for patients with Atopic Dermatitis

Challenge

As objective disease severity scales (BSA, IGA) are not often collected in real-world clinical practice, longitudinal therapeutic escalation can serve as a good surrogate for disease severity.

Solution

Leverage OM1 linked, deep clinical and claims data to illustrate the longitudinal clinical treatment progression and associated outcomes.

*Counts through Q2 2022